Suppr超能文献

卡马西平对伴有慢性疼痛的单相抑郁症患者疼痛评分的影响:一项“停药-用药-停药-用药”设计的试验

Effect of carbamazepine on pain scores of unipolar depressed patients with chronic pain: a trial of off-on-off-on design.

作者信息

Kudoh A, Ishihara H, Matsuki A

机构信息

Department of Anesthesiology, University of Hirosaki School of Medicine, Aomori, Japan.

出版信息

Clin J Pain. 1998 Mar;14(1):61-5. doi: 10.1097/00002508-199803000-00009.

Abstract

OBJECTIVE

The purpose of this study was to evaluate the effect of carbamazepine on chronic pain in patients with major depression.

DESIGN

Off-on-off-on carbamazepine treatment design.

SETTING

Department of Anesthesiology, Hirosaki University Hospital, Japan.

PATIENTS

Fifteen patients with a diagnosis of major depression and chronic pain.

INTERVENTION

Depressed patients maintained on antidepressants that had failed to help depression or pain were initially placed on 450 mg carbamazepine at 150 mg three times per day. Carbamazepine was then increased until the patients experienced satisfactory relief of pain. This dose was then maintained for 3 weeks. Afterward, the medication was stopped, and a lactose placebo was administered orally three times per day for 3 weeks. Thereafter, carbamazepine was given for 3 additional weeks at the dose that previously produced satisfactory pain relief.

OUTCOME MEASURE

Pain scores were assessed four times during the course of the study: before and after the first and the second treatments with carbamazepine, using a visual analog scale in which 0 represents no pain and 10 unbearable pain. The Hamilton Depression scale was used to judge improvement in the symptoms of depression.

RESULTS

Carbamazepine produced a statistically significant reduction in the pain scores, from 8.2 +/- 2.3 to 4.0 +/- 1.1 after the first treatment. The pain score significantly increased to 8.0 +/- 1.0 after stopping carbamazepine, but it decreased significantly to 4.1 +/- 1.8 after the second treatment. The Hamilton scores significantly decreased from 27.4 +/- 7.2 to 20.2 +/- 6.1 after the carbamazepine treatment.

CONCLUSIONS

These results may indicate that carbamazepine has both an antidepressive and an analgesic action in depressed patients. Thus, carbamazepine may offer an acceptable therapeutic option in depressed patients with chronic pain that is unresponsive to antidepressants. Alternatively, these results may indicate that carbamazepine appears to help depression in this group of pain patients because of its analgesic effect (i.e., helps depression as a result of helping pain or vice versa).

摘要

目的

本研究旨在评估卡马西平对重度抑郁症患者慢性疼痛的影响。

设计

卡马西平治疗的开-关-开-关设计。

地点

日本弘前大学医院麻醉科。

患者

15例诊断为重度抑郁症和慢性疼痛的患者。

干预措施

维持服用抗抑郁药但抑郁或疼痛未得到缓解的抑郁症患者,最初给予卡马西平450mg,每日3次,每次150mg。然后增加卡马西平剂量,直至患者疼痛得到满意缓解。该剂量维持3周。之后,停药,给予乳糖安慰剂,每日口服3次,共3周。此后,再次给予卡马西平,剂量为之前产生满意疼痛缓解效果的剂量,持续3周。

观察指标

在研究过程中对疼痛评分进行4次评估:在首次和第二次卡马西平治疗前后,使用视觉模拟量表,其中0表示无疼痛,10表示难以忍受的疼痛。采用汉密尔顿抑郁量表判断抑郁症状的改善情况。

结果

卡马西平使疼痛评分有统计学意义的降低,首次治疗后从8.2±2.3降至4.0±1.1。停用卡马西平后,疼痛评分显著升至8.0±1.0,但第二次治疗后又显著降至4.1±1.8。卡马西平治疗后,汉密尔顿评分从27.4±7.2显著降至20.2±6.1。

结论

这些结果可能表明卡马西平对抑郁症患者具有抗抑郁和镇痛作用。因此,卡马西平可能为对抗抑郁药无反应的慢性疼痛抑郁症患者提供一种可接受的治疗选择。或者,这些结果可能表明卡马西平在这组疼痛患者中似乎有助于缓解抑郁是因其镇痛作用(即通过缓解疼痛来帮助缓解抑郁,反之亦然)。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验